The Tri-Institutional MD-PhD Program (Tri-I) is a joint undertaking between Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center. Trainees complete their MD degree at Weill Cornell Medical College, and PhD training at one of the three participating graduate schools: Weill Cornell Graduate School of Medical Sciences; the David Rockefeller Graduate Program in Bioscience; or the Louis V. Gerstner Jr. Graduate School of Biomedical Sciences. Tri-I guides students through a rigorous course of study that offers flexibility and unfettered access to experienced mentors in leading laboratories. An integrated curriculum reinforces the students’ identities as clinician-scientists; equally well-prepared to work in the laboratory and at the bedside, Tri-I graduates bridge the gap between clinical medicine and laboratory research. 

Learn more about the Tri-Institutional MD-PhD Program by watching the short video below.

For the first time in the program’s history, there are now two Tri-Institutional MD-PhD students who have been named to the Forbes 30 Under 30 list.  Alexendar Pérez, who created a software package for DNA researchers, joins this year’s list. Pérez and 2017 list honoree Kevin O’Rourke, who studies the genetic causes of colon cancer, discussed their experiences with the program and how it contributed to their success.
Jonathan
Gateways alumnus Jonathan Abraham, M.D., Ph.D., has been recently awarded the NIH Director's Early Independence Award for his project Antibody Therapeutics for Human Viral Hemorrhagic Fevers and Prevention of Late Neurological Syndromes.